PATENT CLAIM ANALYSIS

Application Number: 16200004
Application Type: Utility
Filing Date: 2018-11
Publication Date: 2019-03
Patent Classification: ["514", "254060"]

Abstract:
The invention relates to a method for the treatment of vasomotor symptoms comprising the administration of a therapeutically effective amount of flibanserin.

Claim (Index 27):
The method according to  claim 18 , wherein the flibanserin is administered as a pharmaceutically acceptable acid addition salt selected from the salts formed by succinic acid, hydrobromic acid, acetic acid, fumaric acid, maleic acid, methanesulphonic acid, lactic acid, phosphoric acid, hydrochloric acid, sulphuric acid, tartaric acid, citric acid, and mixtures thereof.

Metadata:
- Claim Count in Document: 53.0
- Percentile: 98.0
- Lexical Diversity: 1.21053
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['14583275', '15686665', '12368907', '16125883', '11099155']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.6127584421800302
- 35 USC 102 Novelty (BERT): 0.5301619862149215
- Combined Prediction Score: 0.6044987965835193
- Mean Citation Score: 232.67160400000003
- Max Citation Score: 325.60278
- Similarity Product: 264.889404763627

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test